Investor Relations

Home > Investor Relations > Financial Highlights (consolidated)

Financial Highlights (consolidated)

Change of Principal Management Figures

Settlement of accounts time FY2014
(2014/4/1-2015/3/31)
FY2015
(2015/4/1-2016/3/31)
FY2016
(2016/4/1-2017/3/31)
FY2017
(2017/4/1-2018/3/31)
Net sales
(million yen)
71,470 82,115 84,949 93,430
Operating income
(million yen)
11,105 11,134 6,869 11,643
Ordinary income
(million yen)
15,437 10,157 7,417 11,717
Profit attributable to owners of parent
(million yen)
11,118 7,684 5,576 6,495
Total shareholders' equity
(million yen)
70,048 70,605 74,945 79,920
Total assets
(million yen)
121,187 156,851 165,247 177,325
Shareholders' equity per share
(yen)
4,304.37 4,568.97 4,568.97 4,872.28
Net income per share
(yen)
654.20 462.57 339.96 395.99
Shareholders' equity ratio to total assets 57.8% 45.0% 45.4% 45.1%
Cash dividends per share
(yen)
95.00 95.00 95.00 95.00

Net Sales

Operating Income / Ordinary Income / Net Income

Net Income per Share / Cash Dividends per Share

Shareholders' Equity to Total Assets


Home > Investor Relations > Financial Highlights (consolidated)
© Copyright TOWA PHARMACEUTICAL CO.,LTD. All Rights Reserved.